ClearPoint Neuro, Inc. CLPT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 45.49M | 42.28M | 40.61M | 36.97M | 34.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 45.49M | 42.28M | 40.61M | 36.97M | 34.33M |
| Cost of Revenue | 17.56M | 15.81M | 15.30M | 14.28M | 13.28M |
| Gross Profit | 27.93M | 26.47M | 25.32M | 22.69M | 21.05M |
| SG&A Expenses | 41.82M | 39.87M | 34.96M | 31.16M | 29.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 75.79M | 71.52M | 65.29M | 59.34M | 57.09M |
| Operating Income | -30.30M | -29.24M | -24.68M | -22.36M | -22.76M |
| Income Before Tax | -36.17M | -34.58M | -29.02M | -25.49M | -23.12M |
| Income Tax Expenses | -30.00K | -18.00K | 45.00K | 55.00K | 19.00K |
| Earnings from Continuing Operations | -36.14 | -34.57 | -29.07 | -25.54 | -23.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.14M | -34.57M | -29.07M | -25.54M | -23.14M |
| EBIT | -30.30M | -29.24M | -24.68M | -22.36M | -22.76M |
| EBITDA | -29.02M | -28.21M | -23.61M | -21.48M | -21.95M |
| EPS Basic | -1.21 | -1.18 | -1.01 | -0.90 | -0.83 |
| Normalized Basic EPS | -0.72 | -0.70 | -0.59 | -0.52 | -0.52 |
| EPS Diluted | -1.21 | -1.18 | -1.01 | -0.90 | -0.83 |
| Normalized Diluted EPS | -0.72 | -0.70 | -0.59 | -0.52 | -0.52 |
| Average Basic Shares Outstanding | 119.55M | 116.99M | 115.08M | 113.25M | 112.00M |
| Average Diluted Shares Outstanding | 119.55M | 116.99M | 115.08M | 113.25M | 112.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |